Dovitinib Dilactic acid (TKI258 Dilactic acid)
-
Dovitinib Dilactic acid (TKI258 Dilactic acid)
structure -
-
CAS No:
852433-84-2
-
Formula:
C21H21FN6O.2(C3H6O3)
-
Chemical Name:
Dovitinib Dilactic acid (TKI258 Dilactic acid)
-
Synonyms:
Propanoic acid, 2-hydroxy-, compd. with 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone;Dovitinib dilactic acid, >=99%;Dovitinib Dilactic acid (TKI258 Dilactic acid);2-Hydroxypropanoic acid compd. with 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone;Dovitinib dilactic acid;TKI258 Dilactic acid;Dovitinib (TKI-258) Dilactic Acid
- Categories:
-
CAS No:
Dovitinib Dilactic acid (TKI258 Dilactic acid) Use and Manufacturing
Dovitinib (TKI258, CHIR-258) is a multitargeted tyrosine kinase inhibitor of FLT3 and c-KIT with IC50 of 1 nM and 2 nM, respectively.
Recommended Suppliers of Dovitinib Dilactic acid (TKI258 Dilactic acid)
-
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on Dovitinib Dilactic acid (TKI258 Dilactic acid)
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4
Dovitinib Dilactic acid (TKI258 Dilactic acid)
SDSRequest for Quotation